Drug Shortage Report for TARO-ATORVASTATIN
Report ID | 202098 |
Drug Identification Number | 02313707 |
Brand name | TARO-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-08-10 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-01-05 | French | Compare |
v7 | 2024-01-05 | English | Compare |
v6 | 2023-11-02 | French | Compare |
v5 | 2023-11-02 | English | Compare |
v4 | 2023-08-24 | French | Compare |
v3 | 2023-08-24 | English | Compare |
v2 | 2023-08-16 | French | Compare |
v1 | 2023-08-16 | English | Compare |
Showing 1 to 8 of 8